Emory University a Research News
  a January 14, 2009 a
a a
New WHSC website
MEF2D protein in mouse brain
Toxicity Mechanism Identified for Parkinson's

Neurologists have known for decades that clumps of aggregated proteins called Lewy bodies appear in the brain cells of patients with Parkinson's and other neurodegenerative diseases. The presence of Lewy bodies suggests underlying problems in protein recycling and waste disposal. Scientists think one culprit could be the protein MEF2D. Read more . . .
a a
Dr. Rama Amara
Omer Kucuk, MD
Sound Science: What Fruits and Vegetables Have to Do with Cancer

The idea that food can be used in disease prevention and treatment is far from new. Chinese emperors 6,000 years ago were using soy as medicine. But is wasn't until relatively recently that researchers became keenly interested in exploring foods' medicinal preperties. Oncologist Omer Kucuk studies specific food compounds and their effect on cancer prevention and treatment. Read and listen. .
a a
SECEBT Faces Biologic Threats with Network of Partners

Since 2002 Emory has led the Southeastern Center for Emerging Biologic Threats as a unique regional partnership of research universities and public health agencies focused on the threat of infectious diseases and biologic agents. SECEBT has led eight conferences, awarded seed grants, and maintains an extensive website of resources. Read more . . .
a a
Chronic Fatigue Syndrome
Map of methylation-prone regions of the genome
Rules for Gene Silencing in Cancer Cells Identified
On their way to becoming tumors, cells have to inactivate "tumor suppressor" genes that usually prevent cancer formation. Methylation is a subtle DNA change that tags genes to be inactive. Scientists have found a pattern that predicts which genes are at risk for inactivation in breast and lung cancer. That could make the genes good markers for diagnosis and risk assessment. Read more. . .
a a
Chronic Fatigue Syndrome
Diego Martin, MD, and colleagues
A Better Way to Diagnose Nonalcoholic Fatty Liver Disease
A team of Emory and Georgia Tech scientists has developed a better method of diagnosing nonalcoholic fatty liver disease, a common problem in overweight people. Some go on to develop hepatitis, liver cancer or liver failure, and symptoms often are vague. A new quick, cost-efficient method of diagnosis is less painful and more accurate than liver biopsy. Read more. . .
Woodruff Health Sciences Center
Link to the Current Issue More Research NewsArchives Contact Us Holly Korshun David StephensJeffrey Molter